Alzheimer's is a progressive brain disorder affecting memory, thinking, and behavior. It's a common form of dementia, affecting millions worldwide. There is currently no cure for Alzheimer's, but there are medications that can help manage its symptoms. MLC601 and MLC901 (NeuroAid) are medications that have shown neuroprotective and neuroregenerative properties.
Clinical TrialResearchers investigated the long-term benefits of NeuroAid in patients with Alzheimer's disease. The study included patients diagnosed with Alzheimer's disease based on DSM-IV criteria. The patients were given MLC601 for four years and then switched to MLC901 for another four years.
The researchers used Mini-Mental State Examination (MMSE) and Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) to assess the patient's cognitive function. They also monitored adverse events (AEs) and abnormal findings in physical examinations or lab tests to evaluate safety.